Colchicine Use in Children and Adolescents With Familial Mediterranean Fever: Literature Review and Consensus Statement-Reference-Cited by-同舟云学术

Colchicine Use in Children and Adolescents With Familial Mediterranean Fever: Literature Review and Consensus Statement

Published:2007-02-01 Issue:2 Volume:119 Page:e474-e483
ISSN:0031-4005
Container-title:Pediatrics
language:en
Short-container-title:

Author:

Kallinich Tilmann¹,Haffner Dieter²,Niehues Tim³,Huss Kristina⁴,Lainka Elke⁵,Neudorf Ulrich⁵,Schaefer Christof⁶,Stojanov Silvia⁴,Timmann Christian⁷,Keitzer Rolf¹,Ozdogan Huri⁸,Ozen Seza⁹

Affiliation:

1. Department of Pediatric Pneumology and Immunology, Charité Campus Virchow-Klinikum, Universitaetsmedizin Berlin, Berlin, Germany

2. Department of Pediatrics, University Hospital Rostock, Rostock, Germany

3. Department of Pediatric Oncology, Hematology and Immunology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany

4. Department of Infectious Diseases and Immunology, Children's University Hospital, Munich, Germany

5. Department of Pediatrics, University of Duisburg-Essen, Duisburg, Germany

6. Pharmakovigilanz und Beratungszentrum für Embryonaltoxikologie, Berliner Betrieb für Zentrale Gesundheitliche Aufgaben, Berlin, Germany

7. Department of Molecular Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany

8. Cerrahpasa Faculty of Medicine, University of Istanbul, Cerrahpasa, Turkey

9. Department of Pediatric Nephrology and Rheumatology, Faculty of Medicine, Hacettepe University, Ankara, Turkey

Abstract

The daily application of colchicine is the standard therapy for prophylaxis of attacks and amyloid deposition in familial Mediterranean fever. However, because of many issues (eg, dosage, time of introduction, etc), no standardized treatment recommendations have been established. In this work we review the available literature on colchicine use with respect to its indication, efficacy, mode of application, and safety in children and adolescents with familial Mediterranean fever. On the basis of this analysis, a consensus statement on the application of colchicine in children and adolescents with familial Mediterranean fever was developed by caregivers from Germany, Austria, and Turkey.

Publisher

American Academy of Pediatrics (AAP)

Subject

Pediatrics, Perinatology and Child Health

Link

https://publications.aap.org/pediatrics/article-pdf/119/2/e474/1118242/zpe0020700e474.pdf

Reference142 articles.

1. Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever: a survey of 470 cases and review of the literature. Am J Med. 1967;43:227–253

2. Feldmann W. Evidence-Based Pediatrics. 1st ed. Hamilton, Ontario, Canada: BC Decker; 2000

3. Ben Chetrit E, Levy M. Colchicine: 1998 update. Semin Arthritis Rheum.1998;28:48–59

4. Ertel NH, Mittler JC, Akgun S, Wallace SL. Radioimmunoassay for colchicine in plasma and urine. Science. 1976;193:233–235

5. Tateishi T, Soucek P, Caraco Y, Guengerich FP, Wood AJ. Colchicine biotransformation by human liver microsomes: identification of CYP3A4 as the major isoform responsible for colchicine demethylation. Biochem Pharmacol. 1997;53:111–116

Cited by 219 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Different MEFV Genotypes on Clinical Phenotype of Patients with Familial Mediterranean Fever: Special Emphasis on Joint Involvement;European Journal of Pediatrics;2024-08-07

2. A narrative review on the role of cytokines in the pathogenesis and treatment of familial Mediterranean fever: an emphasis on pediatric cases;Frontiers in Pediatrics;2024-07-26

3. Synthesis and Biological Evaluation of Colchicine─Aryl/Alkyl Amine Hybrids as Potential Noncytotoxic Cholinesterase Inhibitors: Identification of SBN-284 as a Dual Inhibitor of Cholinesterases and NLRP3 Inflammasome;ACS Chemical Neuroscience;2024-07-26

4. An “On Demand” canakinumab regimen for treating children with Colchicine-Resistant familial Mediterranean fever – A multicentre study;International Immunopharmacology;2024-05

5. Acute Myopericarditis as the First Manifestation of Familial Mediterranean Fever: A Case Report;Cureus;2024-02-14